AMERICAN ONCOLOGY NETWORK INC.

NASDAQ: AONC (American Oncology Network, Inc.)

Kemas kini terakhir: 05 Jul, 8:18PM

13.01

-0.79 (-5.72%)

Penutupan Terdahulu 13.80
Buka 13.50
Jumlah Dagangan 3,700
Purata Dagangan (3B) 3,608
Modal Pasaran 380,521,696
Harga / Jualan (P/S) 0.280
Julat 52 Minggu
1.13 (-91%) — 14.25 (9%)
Tarikh Pendapatan 7 Jul 2025
Margin Keuntungan -0.23%
Margin Operasi (TTM) 1.70%
EPS Cair (TTM) -0.890
Pertumbuhan Hasil Suku Tahunan (YOY) 51.40%
Jumlah Hutang/Ekuiti (D/E MRQ) 139.57%
Nisbah Semasa (MRQ) 1.53
Aliran Tunai Operasi (OCF TTM) -4.94 M
Aliran Tunai Bebas Leveraj (LFCF TTM) -34.62 M
Pulangan Atas Aset (ROA TTM) -2.38%
Pulangan Atas Ekuiti (ROE TTM) -30.17%

Arah Aliran Pasaran

Jangka Pendek Jangka Sederhana
Industri Medical Care Facilities (US) Menurun Bercampur
Medical Care Facilities (Global) Bercampur Bercampur
Stok American Oncology Network, Inc. - -

AISkor Stockmoo

-0.3
Konsensus Penganalisis -2.0
Aktiviti Orang Dalam NA
Volatiliti Harga -3.0
Purata Bergerak Teknikal 1.5
Osilator Teknikal 2.5
Purata -0.25

Saham Serupa

Stok Modal Pasaran DY P/E (TTM) P/B
AONC 381 M - - -
CMPS 389 M - - 1.69
BMGL 20 M - 11.33 7.45
PAIYY 6 M - - 1.59
NIVF 3 M - - 7.15
PIIIW - - - -

American Oncology Network Inc is an alliance of physicians and seasoned healthcare leaders partnering to ensure the long-term success and viability of community oncology and other specialties. The company pioneers innovative healthcare solutions through its physician-led model, fostering value-based care that improves patient outcomes while reducing costs and expanding access to quality care. It is committed to promoting health equity by addressing disparities in cancer care and ensuring that all patients have access to the care they need to achieve optimal health outcomes.

Sektor Healthcare
Industri Medical Care Facilities
% Dimiliki oleh Orang Dalam 77.99%
% Dimiliki oleh Institusi 0.08%

Tiada data dalam julat masa ini.

Tiada data dalam julat masa ini.

Tarikh Jenis Butiran
15 Jul 2025 Pengumuman Auerbach Hematology and Oncology Joins American Oncology Network, Becomes The Center for Cancer and Blood Disorders – Baltimore
15 Jul 2025 Pengumuman Florida Oncology and Hematology Expands Fort Myers Clinic, Adds PET Services
08 Jul 2025 Pengumuman Hope Cancer Care of Nevada and American Oncology Network Open New Henderson Clinic
01 Jul 2025 Pengumuman Florida Oncology and Hematology Relocates Naples Health Parkway Clinic to Larger Location in Lintree Medical Plaza; Adds PET Services
11 Jun 2025 Pengumuman Florida Oncology and Hematology Moves Naples-Goodlette Clinic to Larger Location
03 Jun 2025 Pengumuman American Oncology Network Announces Research Studies Presented at ASCO 2025 Annual Meeting
21 May 2025 Pengumuman American Oncology Network Expands Access to Advanced Radioligand Therapies Across U.S. Network
15 May 2025 Pengumuman American Oncology Network Appoints Joe Verschleiser as Chief Growth and Performance Officer
14 May 2025 Pengumuman Heartland Oncology and Hematology Oncologist Named 2025 Advocacy Champion by the Association for Clinical Oncology (ASCO)
13 May 2025 Pengumuman American Oncology Network Appoints Terri Casey as Chief Human Resources Officer
24 Apr 2025 Pengumuman American Oncology Network to Participate in 14 Sessions at 2025 Community Oncology Alliance Annual Conference
22 Apr 2025 Pengumuman American Oncology Network Achieves Success in First Performance Period of CMMI’s Enhancing Oncology Model
Papar semua
14.5014.5013.5113.5112.5112.5111.5211.5210.5310.53Jun 24Jun 24Jun 25Jun 25Jun 26Jun 26Jun 27Jun 27Jun 30Jun 30Jul 1Jul 1Jul 2Jul 2Jul 3Jul 3

Tahap sokongan, rintangan dan garis aliran yang dibentangkan telah dihasilkan oleh model kecerdasan buatan (AI) dan harus ditafsirkan dengan berhati-hati.

10010075755050252500RSI (14H)
2.0002.0001.5001.5001.0001.0000.5000.5000.0000.000MACD (12, 26, 9)

Portfolio

AI Templat

Peringatan harga anda

Profil Risiko

| | | | |
Konservatif
Sederhana Konservatif
Sederhana
Sederhana Agresif
Agresif
Margin Keselamatan (EP)
Keuntungan Separa (TP1)
Keuntungan Sasaran (TP2)
Kerugian Maksimum (SL)

Penafian: Perkara di atas adalah untuk tujuan ilustrasi sahaja dan BUKAN nasihat pelaburan. Dapatkan nasihat daripada penasihat kewangan yang berkelayakan.

Harga Masuk (EP)

Ambil Untung 1 (TP1)

Ambil Untung 2 (TP2)

Henti Rugi (SL)

Julat 52 Minggu
 
52WL
 
52WH
SL
EP
TP1
TP2

Semua harga peringatan berada dalam julat harga 52 minggu

Keuntungan Nyata -
Keuntungan Tidak Nyata -
Dividen Diterima 2025 -
Jumlah Untung -
Pulangan Purata -
Kuantiti (Beli) -
Purata Harga (Beli) -
Kuantiti (Jual) -
Purata Harga (Jual) -
Tiada saham yang memenuhi kriteria anda